Radiation Therapy for Head and Neck Cancers

Seminars in Oncology Nursing

Volumn 25, Issue 3, 2009, Pages 193-202

  Mallick, Indranil ^a   Waldron, John N ^a  

^a NONE

Author keywords

Head and neck cancers; radiotherapy; supportive care; treatment toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; HEAD AND NECK TUMOR; HUMAN; NURSING; RADIATION DOSE FRACTIONATION; RADIOTHERAPY;

ANTINEOPLASTIC AGENTS; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY;

EID: 67650918538     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2009.05.002     Document Type: Article

References (49)

1. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
2. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
3. Jabbari S., Kim H.M., Feng M., et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63 (2005) 725-731
4. Cannon D.M., and Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 660-665
5. Hall E.J. The inaugural Frank Ellis Lecture-Latrogenic cancer: the impact of intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 18 (2006) 277-282
6. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
7. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
8. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
9. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
10. Waldron J., Warde P., Irish J., et al. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer. Radiother Oncol 87 (2008) 173-180
11. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
12. Dische S., and Saunders M.I. The CHART regimen and morbidity. Acta Oncol 38 (1999) 147-152
13. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
14. Pignon J.P., le Maitre A., and Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 (2007) S112-S114
15. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
16. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
17. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
18. Pedruzzi P.A., Kowalski L.P., Nishimoto I.N., et al. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 134 (2008) 1196-1204
19. Nguyen N.P., North D., Smith H.J., et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 15 (2006) 199-203
20. Wiggenraad R.G., Flierman L., Goossens A., et al. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol 32 (2007) 384-390
21. Jham B.C., Reis P.M., Miranda E.L., et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Invest 12 (2008) 19-24
22. Nguyen N.P., Frank C., Moltz C.C., et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol 80 (2006) 302-306
23. Cawley M.M., and Benson L.M. Current trends in managing oral mucositis. Clin J Oncol Nurs 9 (2005) 584-592
24. Harris D.J., Eilers J., Harriman A., et al. Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs 12 (2008) 141-152
25. Rubenstein E.B., Peterson D.E., Schubert M., et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 (2004) 2026-2046
26. Quinn B., Potting C.M., Stone R., et al. Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44 (2008) 61-72
27. Keefe D.M., Schubert M.M., Elting L.S., et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109 (2007) 820-831
28. Rosenthal D.I., and Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19 (2009) 29-34
29. Colasanto J.M., Prasad P., Nash M.A., et al. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology (Williston Park) 19 (2005) 371-379 discussion 380-372, 387
30. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
31. Miller E.H., and Quinn A.I. Dental considerations in the management of head and neck cancer patients. Otolaryngol Clin North Am 39 (2006) 319-329
32. Bolderston A., Lloyd N.S., Wong R.K., et al. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer 14 (2006) 802-817
33. McQuestion M. Evidence-based skin care management in radiation therapy. Semin Oncol Nurs 22 (2006) 163-173
34. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
35. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
36. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
37. Rudat V., Munter M., Rades D., et al. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol 89 (2008) 71-80
38. Eisbruch A. Reducing xerostomia by IMRT: what may, and may not, be achieved. J Clin Oncol 25 (2007) 4863-4864
39. Ruo Redda M.G., and Allis S. Radiotherapy-induced taste impairment. Cancer Treat Rev 32 (2006) 541-547
40. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
41. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 (2007) 1289-1298
42. Gillespie M.B., Brodsky M.B., Day T.A., et al. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114 (2004) 1362-1367
43. Jereczek-Fossa B.A., and Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28 (2002) 65-74
44. Pitak-Arnnop P., Sader R., Dhanuthai K., et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol 34 (2008) 1123-1134
45. Tell R., Sjodin H., Lundell G., et al. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 39 (1997) 303-308
46. Garcia-Serra A., Amdur R.J., Morris C.G., et al. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 28 (2005) 255-258
47. Abayomi O.K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 41 (2002) 346-351
48. Yuen H.K., Sharma A.K., Logan W.C., et al. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol 87 (2008) 304-307
49. Cheung M., Chan A.S., Law S.C., et al. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol 57 (2000) 1347-1352